The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
3-amino-6-(cyclohexylmethyl)-4-(furan-2-yl)thieno[2,3-b]pyridine-2-carboxamide ID: ALA1089298
PubChem CID: 46884358
Max Phase: Preclinical
Molecular Formula: C19H21N3O2S
Molecular Weight: 355.46
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: NC(=O)c1sc2nc(CC3CCCCC3)cc(-c3ccco3)c2c1N
Standard InChI: InChI=1S/C19H21N3O2S/c20-16-15-13(14-7-4-8-24-14)10-12(9-11-5-2-1-3-6-11)22-19(15)25-17(16)18(21)23/h4,7-8,10-11H,1-3,5-6,9,20H2,(H2,21,23)
Standard InChI Key: LXLJXSRRBGCWEF-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 28 0 0 0 0 0 0 0 0999 V2000
6.3268 -23.8561 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3668 -23.0309 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6732 -22.5856 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9392 -22.9643 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9031 -23.7928 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5975 -24.2344 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7589 -23.0342 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7558 -23.8607 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.4688 -24.2748 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.4710 -22.6236 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.1846 -23.0340 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.1821 -23.8658 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.9724 -24.1253 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
10.4635 -23.4538 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.9766 -22.7794 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.2339 -21.9956 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.2885 -23.4563 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.6988 -24.1721 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
11.7032 -22.7431 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.4705 -21.7986 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.1325 -21.3134 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.8771 -20.5289 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0520 -20.5293 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7977 -21.3141 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.0400 -24.2709 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6 1 1 0
1 2 1 0
3 4 1 0
12 13 1 0
13 14 1 0
14 15 2 0
15 11 1 0
7 8 2 0
15 16 1 0
14 17 1 0
8 9 1 0
17 18 2 0
9 12 2 0
17 19 1 0
4 5 1 0
10 20 1 0
20 21 2 0
11 10 2 0
10 7 1 0
11 12 1 0
2 3 1 0
21 22 1 0
22 23 2 0
23 24 1 0
24 20 1 0
5 6 1 0
8 25 1 0
25 1 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 355.46Molecular Weight (Monoisotopic): 355.1354AlogP: 4.36#Rotatable Bonds: 4Polar Surface Area: 95.14Molecular Species: NEUTRALHBA: 5HBD: 2#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): 4#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: ┄CX LogP: 3.94CX LogD: 3.94Aromatic Rings: 3Heavy Atoms: 25QED Weighted: 0.73Np Likeness Score: -1.35
References 1. Lockman JW, Reeder MD, Suzuki K, Ostanin K, Hoff R, Bhoite L, Austin H, Baichwal V, Adam Willardsen J.. (2010) Inhibition of eEF2-K by thieno[2,3-b]pyridine analogues., 20 (7): [PMID:20189382 ] [10.1016/j.bmcl.2010.02.005 ]